Development of a digital therapeutic intervention to treat acute stress.
The THERASONAR project promotes a solution to combat acute stress made up of a back-office platform for professionals and a mobile application for final patients, preventing them from becoming chronic.
To do this, THERASONAR develops a voice analysis technology using algorithms capable of recognising emotions to offer specific and personalised stress treatment programs through advanced audio formats to distribute them through an application.
In addition, within the framework of the project, technologies for digital phenotyping, state-of-the-art sound therapy and clinical decision support for therapeutic personalisation are developed.
The platform also integrates conversational and empathic artificial intelligence, which serves as a guide for clinical intervention in a more convenient way and offers a more humane experience, as well as prescription and monitoring capabilities for patients participating in the technology validation process.
The THERASONAR consortium is led by the company WeVoice and Eurecat, which participates through its Digital Health and Audiovisual Technologies Units. In addition, the project has the participation of the Biomedical Research Institute of Malaga (IBIMA).
General details
Project
THERASONAR – Personalised digital sound therapy based on evidence and value
Project reference
CPP2021-008743
Programme and call for tender
Project funded by the Spanish Ministry of Science and Innovation through the call “R+D+i Projects in Public-Private Collaboration”, State Program to Promote Scientific and Technical Research and its Transfer, from the State Plan for Scientific, Technical Research and Innovation 2021-2023, within the framework of the Recovery, Transformation and Resilience Plan
